- Home
- PAPL vs BJDX Comparison
PAPL vs BJDX Comparison
Compare PAPL & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAPL
- BJDX
- Stock Information
- Founded
- PAPL 2015
- BJDX 2015
- Country
- PAPL Canada
- BJDX United States
- Employees
- PAPL N/A
- BJDX N/A
- Industry
- PAPL Finance: Consumer Services
- BJDX Medical Specialities
- Sector
- PAPL Finance
- BJDX Health Care
- Exchange
- PAPL Nasdaq
- BJDX Nasdaq
- Market Cap
- PAPL 2.8M
- BJDX 2.2M
- IPO Year
- PAPL 2023
- BJDX 2021
- Fundamental
- Price
- PAPL $0.11
- BJDX $1.76
- Analyst Decision
- PAPL Strong Buy
- BJDX
- Analyst Count
- PAPL 2
- BJDX 0
- Target Price
- PAPL $5.25
- BJDX N/A
- AVG Volume (30 Days)
- PAPL 2.7M
- BJDX 537.4K
- Earning Date
- PAPL 04-14-2025
- BJDX 05-19-2025
- Dividend Yield
- PAPL N/A
- BJDX N/A
- EPS Growth
- PAPL N/A
- BJDX N/A
- EPS
- PAPL N/A
- BJDX N/A
- Revenue
- PAPL $2,848,365.00
- BJDX N/A
- Revenue This Year
- PAPL $7.18
- BJDX N/A
- Revenue Next Year
- PAPL $25.02
- BJDX $55.56
- P/E Ratio
- PAPL N/A
- BJDX N/A
- Revenue Growth
- PAPL 13.01
- BJDX N/A
- 52 Week Low
- PAPL $0.11
- BJDX $1.46
- 52 Week High
- PAPL $2.10
- BJDX $316.80
- Technical
- Relative Strength Index (RSI)
- PAPL 18.51
- BJDX 40.67
- Support Level
- PAPL $0.11
- BJDX $1.70
- Resistance Level
- PAPL $0.15
- BJDX $2.33
- Average True Range (ATR)
- PAPL 0.03
- BJDX 0.21
- MACD
- PAPL -0.01
- BJDX 0.05
- Stochastic Oscillator
- PAPL 5.21
- BJDX 34.48
About PAPL Pineapple Financial Inc.
Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.